93 related articles for article (PubMed ID: 19007367)
1. The National Institute of Health and Clinical Excellence rejects new treatments for renal cell cancer: Cinderella's invitation is cancelled.
Eisen T
BJU Int; 2008 Dec; 102(11):1491-2. PubMed ID: 19007367
[No Abstract] [Full Text] [Related]
2. Welcome clinical leadership at NICE.
Lancet; 2008 Aug; 372(9639):601. PubMed ID: 18722845
[No Abstract] [Full Text] [Related]
3. NICE guidance on cabozantinib for previously treated advanced renal cell carcinoma.
Elsada A; Adler AI
Lancet Oncol; 2017 Sep; 18(9):1153-1154. PubMed ID: 28800862
[No Abstract] [Full Text] [Related]
4. The Authors Respond.
Delea TE; Amdahl J; Diaz J; Nakhaipour HR; El Khoury MH
J Manag Care Spec Pharm; 2015 Sep; 21(9):836-40. PubMed ID: 26536676
[No Abstract] [Full Text] [Related]
5. Where to draw the lifeline?
Siva N
Nat Clin Pract Urol; 2008 Dec; 5(12):637. PubMed ID: 19050707
[No Abstract] [Full Text] [Related]
6. Health economics: Life in the balance.
Cressey D
Nature; 2009 Sep; 461(7262):336-9. PubMed ID: 19759594
[No Abstract] [Full Text] [Related]
7. The Costly War Against Cancer Treatment: The Example of Metastatic Renal Cell Carcinoma in Portugal.
Barata PC; Alpuim Costa D; Passos Coelho JL; Da Luz R
Acta Med Port; 2018 Aug; 31(7-8):373-375. PubMed ID: 30189164
[No Abstract] [Full Text] [Related]
8. ["... and now about the costs!"].
Rohde D
Aktuelle Urol; 2008 Jan; 39(1):2 p preceding table of contents. PubMed ID: 18303603
[No Abstract] [Full Text] [Related]
9. Advances in chemotherapy for renal cell carcinoma.
Huben RP
Semin Urol; 1992 Feb; 10(1):16-22. PubMed ID: 1565899
[No Abstract] [Full Text] [Related]
10. [Clinical study on the effects of chemotherapy as treatment of renal cell carcinoma].
Onishi T; Iizuka N; Suzuki M; Mori Y; Kondo I; Nakada J; Masuda F; Machida T
Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):43-9. PubMed ID: 3379331
[No Abstract] [Full Text] [Related]
11. Chemotherapy for renal cell carcinoma.
Amato RJ
Semin Oncol; 2000 Apr; 27(2):177-86. PubMed ID: 10768596
[TBL] [Abstract][Full Text] [Related]
12. Advanced renal cell carcinoma in Australia, 2015: what should we do?
Davis ID
Asia Pac J Clin Oncol; 2014 Dec; 10(4):285-8. PubMed ID: 25392943
[No Abstract] [Full Text] [Related]
13. [Current status of chemotherapy for renal cell carcinoma].
Kato T; Sato K
Gan To Kagaku Ryoho; 1994 Jan; 21(1):23-8. PubMed ID: 8291912
[TBL] [Abstract][Full Text] [Related]
14. Temsirolimus for advanced renal-cell carcinoma.
Ferretti G
N Engl J Med; 2007 Sep; 357(10):1050; author reply 1050-1. PubMed ID: 17823993
[No Abstract] [Full Text] [Related]
15. Cytotoxic chemotherapy for advanced renal cell carcinoma.
Yagoda A; Petrylak D; Thompson S
Urol Clin North Am; 1993 May; 20(2):303-21. PubMed ID: 8493752
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab and everolimus in renal cancer: a rational way forward.
Stadler WM; Phillips G; George DJ; Halabi S; Small E
J Clin Oncol; 2010 Nov; 28(33):e692-3; author reply e694. PubMed ID: 20940194
[No Abstract] [Full Text] [Related]
17. Phase II cytotoxic chemotherapy trials in renal cell carcinoma: 1983-1988.
Yagoda A
Prog Clin Biol Res; 1990; 350():227-41. PubMed ID: 2201045
[No Abstract] [Full Text] [Related]
18. Renal cell carcinoma therapy in 2010: many options with little comparative data.
Pal SK; Figlin RA
Clin Adv Hematol Oncol; 2010 Mar; 8(3):191-200. PubMed ID: 20400934
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study of UFT in far-advanced renal cell carcinoma].
Matsuyama H; Yamamoto N; Sakatoku J; Hara Y; Sacho T; Yasui H; Ichikawa T; Koshido Y; Hayasida S; Nagata K
Gan To Kagaku Ryoho; 1988 Mar; 15(3):527-30. PubMed ID: 3126711
[No Abstract] [Full Text] [Related]
20. Efficacy of UFT for the treatment of renal cell carcinoma.
Masuda F; Mori Y; Nakada J
Prog Clin Biol Res; 1989; 303():707-9. PubMed ID: 2506559
[No Abstract] [Full Text] [Related]
[Next] [New Search]
